Guifu Dihuang Pills Ameliorated Mucus Hypersecretion by Suppressing Muc5ac Expression and Inactivating the ERK-SP1 Pathway in Lipopolysaccharide/Cigarette Smoke-Induced Mice

Guifu Dihuang Pills Ameliorated Mucus Hypersecretion by Suppressing Muc5ac Expression and Inactivating the ERK-SP1 Pathway in Lipopolysaccharide/Cigarette Smoke-Induced Mice

Mucus hypersecretion is a hallmark of chronic obstructive pulmonary disease (COPD) and is associated with increasing sputum production and declining pulmonary function. Therefore, reducing mucus secretion can be a new therapeutic opportunity for preventing COPD. The Guifu Dihuang pill (GFDHP) is a c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Huanhuan Zhang, Wenying Yu, Liting Ji, Yusen Zhong, Yiyou Lin, Huazhong Ying, Chenhuan Yu, Changyu Li
Formato: article
Lenguaje:EN
Publicado: Hindawi Limited 2021
Materias:
Other systems of medicine
RZ201-999
Acceso en línea:https://doaj.org/article/2cd966e7d80644079f24bc378f97392c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares